In eukaryotic cells, the ribosome-Sec61 translocon complex (RTC) establishes membrane protein topology by cotranslationally partitioning nascent polypeptides into the cytosol, ER lumen, and lipid bilayer. Using photocrosslinking, collisional quenching, cysteine accessibility, and protease protection, we show that a canonical type II signal anchor (SA) acquires its topology through four tightly coupled and mechanistically distinct steps: (1) head-first insertion into Sec61a, (2) nascent chain accumulation within the RTC, (3) inversion from type I to type II topology, and (4) stable translocation of C-terminal flanking residues. Progression through each stage is induced by incremental increases in chain length and involves abrupt changes in the molecular environment of the SA. Importantly, type II SA inversion deviates from a type I SA at an unstable intermediate whose topology is controlled by dynamic interactions between the ribosome and translocon. Thus, the RTC coordinates SA topogenesis within a protected environment via sequential energetic transitions of the TM segment.
INTRODUCTION
The biogenesis of most eukaryotic membrane proteins requires selective delivery of nascent polypeptide domains into the endoplasmic reticulum (ER) lumen, the ER membrane, and the cytosol (Skach, 2009; von Heijne, 2006 ). This process is initiated when a signal sequence emerges from the ribosome, binds signal recognition particle (SRP), and targets the ribosome and nascent chain to a membrane protein complex (translocon) comprising the Sec61abg protein conducting channel (PCC) and its associated proteins: TRAP, TRAM, oligosaccharyltransferase, signal peptidase, and others (Johnson and van Waes, 1999; Rapoport, 2007; Shibatani et al., 2005) . The X-ray crystal structure of an archaebacterial Sec61 homolog identified key structural features of the PCC, i.e., a signal sequence-binding site, hourglassshaped pore, and lateral gate (van den Berg et al., 2004) . Insertion of the signal sequence into the PCC is proposed to open the pore, strengthen ribosome binding to Sec61 (Becker et al., 2009; Cheng et al., 2005; Jungnickel and Rapoport, 1995; Song et al., 2000) , and establish an aqueous translocation pathway that extends from the ribosome exit tunnel into the ER lumen (Crowley et al., 1993 (Crowley et al., , 1994 . Most secretory proteins and extracytosolic domains of transmembrane proteins move through this pathway coincident with polypeptide elongation (Mothes et al., 1994; Thrift et al., 1991) , whereas membrane protein translocation is interrupted by synthesis of hydrophobic transmembrane segments (Liao et al., 1997) that are transferred laterally into the lipid bilayer (Ismail et al., 2008; Junne et al., 2010; Pitonzo et al., 2009) .
Signal anchor (SA) sequences, like signal sequences, facilitate SRP-mediated ER targeting to the translocon but ultimately form helical transmembrane segments (TMs) that span the bilayer in either a type I (N exo /C cyto ) or a type II (N cyto /C exo ) topology (Higy et al., 2004) . The final topology of an SA is the product of several factors that include (1) flanking charged residues, (2) hydrophobicity, (3) folding of the N-terminal domain, (4) attachment of N-linked carbohydrates, and (5) composition of membrane lipids (Denzer et al., 1995; Dowhan and Bogdanov, 2009; Goder et al., 1999; Higy et al., 2004) . Among these, flanking charges and hydrophobicity provide the energetics that drive topogenesis, while folding and glycosylation create a kinetic block that biases the final topological outcome (Higy et al., 2004) . Because type II SAs translocate their C-terminal flanking residues into the ER lumen, they must invert end-over-end 180 after exiting the ribosome in order to achieve their proper topology in the bilayer. Little is known about when and how such an inversion might take place in the context of the assembled ribosome translocon complex (RTC). One possibility is that the SA might invert prior to insertion in a tail-first, hairpin-looped configuration as has been proposed for N-terminal signal sequences (Rapoport, 2007; Shaw et al., 1988) . Alternatively, in vivo studies show that model SAs can insert head-first into the translocon (Goder and Spiess, 2003) . These results implicate distinctly different mechanisms as to how the RTC coordinates proper localization of the nascent chain. Specifically, is SA topology established within the proteinaceous environment of the translocon or after the TM segment has integrated into the lipid bilayer? How is nascent chain delivery to the ER lumen and cytosol controlled? And, what role does ribosome binding play in SA topogenesis?
To reconstruct the events of type II SA biogenesis, we examined a canonical SA derived from the first TM segment of the aquaporin 4 water channel (AQP4-TM1). Aquaporins (AQPs) are ubiquitous six-spanning polytopic proteins that facilitate water and/or glycerol transport across cell membranes (King et al., 2004) . AQP4 utilizes a cotranslational mode of biogenesis in which individual TM segments encode alternating SA and stop transfer sequences that interact with Sec61 and direct each successive peptide loop onto opposite sides of the ER membrane (Foster et al., 2000; Sadlish et al., 2005) . Consistent with this, AQP4-TM1 targets the ribosome nascent chain complex (RNC) to the ER, inserts into Sec61a, and integrates into the membrane in a type II topology independent of downstream TMs. We now show that this topology is established via four mechanistically distinct steps that begin with head-first insertion of the TM into a sequestered environment within the RTC. Each step is triggered by incremental changes in nascent chain length and coincides with major changes in the molecular environment of the SA. Importantly, the key transition from a type I to a type II topology involves a metastable intermediate whose premature access to the cytosol is prevented by reversible electrostatic interactions at the ribosome-translocon junction. Type I and type II SA topogenesis diverges at this late stage of TM inversion to give rise to different topological outcomes.
RESULTS

Experimental Strategy
SA topogenesis was characterized using assembled integration intermediates that contained AQP4-TM1 fused to a well-characterized passive C terminus reporter domain (Foster et al., 2000; Rothman et al., 1988) (Figure 1A ). Transcripts were truncated at sequential sites in the coding sequence and translated in vitro to generate uniform cohorts of nascent chains that remain attached to membrane-bound ribosomes via an intact peptidyltRNA bond. Each truncated intermediate therefore provides a static snapshot of nascent chain architecture within a fully assembled RTC at a defined stage of synthesis. By analyzing serially truncated intermediates, it is possible to reconstruct progressive changes in the molecular environment, transmembrane orientation, and cytosolic/lumenal accessibility of TM1 and its flanking residues. The combined use of site-specific photocrosslinking, fluorescence collisional quenching, cysteine accessibility, and protease digestion assess multiple features of the nascent chain and provide a detailed consensus of the sequential steps by which the RTC facilitates SA topogenesis.
Type II SA Targeting to the ER and Insertion into the RTC To determine when the RNC first targets to the ER, translation was carried out in the presence of ER microsomes, and membrane-bound nascent chains were isolated and quantified ( Figures 1A and 1B) . Evaluation of peptidyl-tRNA bands, which reflect intact RNCs, revealed that AQP4-TM1 initiates ER targeting at a nascent chain length of 66-71 aa when its C-terminal boundary has extended approximately 35 residues from ribosome peptidyltransferase center (PTC) ( Figures 1A and 1B) . Thus, the threshold for targeting occurs just as TM1 emerges from the ribosome exit tunnel. In addition, RNC attachment to the ER was partially salt sensitive at truncations 66-71 aa but became salt resistant for nascent chains 77 aa and longer ( Figure 1B) .
We next characterized the molecular environment of TM1 within the RTC by inserting a photocrosslinking probe 3ANB-Lys near the center of TM1 at an engineered amber (UAG) codon (Leu28TAG) using a modified suppressor aminoacyl-tRNA (3ANB-Lys-tRNA amb ). Ribosomes that read through the stop codon incorporate 3ANB-Lys and continue translating to the end of the truncated transcript, thereby positioning the probe at a specific location within the RTC. Upon UV irradiation, the ANB moiety generates a reactive, short-lived nitrene that promiscuously crosslinks adjacent proteins within reach of the 12 Å spacer arm (McCormick et al., 2003; Sadlish et al., 2005) . The efficiency of photoadduct formation therefore approximates the relative proximity of the probe to neighboring proteins. Quantitative immunoprecipitation of photoadducts (described in Sadlish et al., 2005 and Figures S1A and S1B available online) revealed three distinct phases of TM1 photocrosslinking to Sec61a. First, relatively weak photoadducts were detected coincident with RNC binding to the ER membrane (truncations 66-77, Figures 1C and 1D ). Second, photoadducts increased in intensity nearly 10-fold as the nascent chain was extended to 98 residues in length. Third, photocrosslinking efficiency abruptly decreased at truncation 103 and then persisted at an intermediate level. TM1 therefore resides at a site proximal enough to crosslink Sec61a at the earliest stage of membrane targeting and gradually engages the translocon in a more favorable conformation before experiencing an abrupt change in environment as the nascent chain is lengthened just 5 residues, from 98 aa to 103 aa. Residue 44, which is 7 aa C-terminal to TM1, also crosslinked Sec61a (even more efficiently than residue 28) at the earliest stage of ER targeting (truncation 71, Figure 1E and Figure S1C ). Because the 3ANB-Lys probe is only 27 residues from the PTC at this stage of synthesis, it likely resides near the end of the ribosome exit tunnel where it contacts cytosolic loops of Sec61a (Becker et al., 2009) . In contrast, residue 65 initially crosslinked Sec61a at truncation 98. The latter photoadducts increased in intensity as the nascent chain was extended to 110 and 133 aa while corresponding crosslinks to residues 28 and 44 decreased ( Figure 1E and Figure S1C ). Interestingly, residue 2 did not crosslink Sec61a, but did crosslink TRAM, weakly at truncation 88 and more strongly at truncations 110 and 133, consistent with previous reports for N-terminal residues of cleaved signal sequences ( Figure 1F and High et al., 1993) . These results identify multiple translocon components proximal to different regions of the nascent chain and demonstrate that TM1 and its flanking residues undergo dynamic transitions within the molecular environment of the RTC that are tightly coordinated with nascent chain elongation.
TM1 Inserts into the Translocon in a Head-First, or Type I, Topology A critical aspect of membrane protein topogenesis is the mechanism by which the RTC selectively delivers polypeptide into the cytosol and ER lumen. This process can be monitored in functionally engaged RTCs by incorporating a fluorescent dye into the nascent chain and measuring the extent of fluorescence quenching by a membrane-impermeable quenching agent (Johnson, 2005) . The ratio of fluorescence intensity in the absence and presence of quencher therefore provides a direct measure of the dye's accessibility to the compartment containing the quenching agent. In this system, surface exposed cytosolic residues exhibit a relatively high quenching constant (K sv $4 M À1 , Crowley et al., 1993) that is reduced following translocation into the ER lumen and restored by membrane permeabilization ( Figure S2 ). Using this approach, we determined the transmembrane orientation of TM1 at the earliest stage of ER targeting (truncation 71) by comparing the Stern Volmer quenching constant (K sv ) in intact and melittin-permeabilized RTCs (Figure 2) . A fluorescently labeled amino acid, 3NBD-Lys was incorporated at amber codons located at residue 2 or residue 44 using a synthetic T S P T S P T S P T S P T S P T S P (C) Translation products containing a photoactive crosslinker (3ANB-Lys) at residue 28 (and WT constructs lacking UAG codon) were UV irradiated and pelleted. Translation products were quantified by phosphorimaging (see also Figure S1 ). Equal amounts were immunoprecipitated with Sec61a antisera and subjected to SDS-PAGE.
(D) Quantification of photocrosslinks (as in C) after correcting for WT signal.
(E and F) Autoradiogram showing photoadducts to residues 2, 28, 44, and 65 immunoprecipitated with Sec61a (E) or TRAM (F). Graphs show mean (n R 3 ± SEM).
suppressor tRNA (3NBD-Lys-tRNA amb ). In the absence of ER microsomes, probes located both N-and C-terminal to TM1 yielded K sv values typical for surface exposed residues, 4.2 ± 0.3 and 4.2 ± 0.3, respectively (Figures 2B and 2C) . In contrast, both probes were shielded from cytosolic iodide ions (I À ) following ER targeting (K sv = 2.1 ± 0.1 and 1.8 ± 0.4, respectively). Surprisingly, membrane permeabilization restored quenching of residue 2 (K sv = 3.8 ± 0.4), but not residue 44 (K sv = 2.2 ± 0.8). Because the extent of V2NBD-Lys quenching following permeabilization was indistinguishable from free RNCs, the N terminus of TM1 becomes accessible to the ER lumen upon membrane targeting. In contrast, residue 44, which is located near the cytosolic vestibule of Sec61a, remained shielded from both lumenal and cytosolic I À ( Figure 2C ). These findings, together with crosslinking results shown in Figure 1 , suggest that AQP4-TM1 initially inserts into the translocon at a site proximal to Sec61a in a ''head-first'' (type I) topology.
Inversion of TM1 from a Type I to a Type II Topology To determine the stage of synthesis at which TM1 begins to attain a type II topology, we measured quenching constants for V2NBD-Lys and L44NBD-Lys as the nascent chain was extended from 71 to 133 aa. V2NBD-Lys remained accessible to lumenal I -during synthesis of approximately 27 additional residues (truncations 71 aa to 98 aa) as demonstrated by an initial low K sv and a $2 fold increase after membrane permeabilization ( Figure 3A ). In contrast, L44NBD-Lys continued to exhibit low I À accessibility both before and after permeabilization (Figure 3B) . At truncation 98, residue 44 is 54 aa from the PTC and has likely emerged from the ribosome exit tunnel. Yet the low level of quenching indicates that this region of nascent chain
has not yet passed through the translocon pore. Because residue 44 crosslinks Sec61a at this truncation, ( Figure 1E ), we conclude that TM1 C-terminal flanking residues accumulate near the ribosome exit site and cytosolic vestibule of the translocon in an environment that is relatively inaccessible from both the cytosol and ER lumen ( Figure 3C ). As the nascent chain was extended from 98 aa to 110 aa, residue 44 abruptly became accessible to lumenal I À as demonstrated by a 2-fold increase in K sv upon membrane permeabilization ( Figure 3B ). V2NBD-Lys also exhibited a reduction in ΔK sv following membrane permeabilization ( Figure 3A ), although the extent of V2NBD-Lys quenching was less than expected for a fully exposed residue. This latter finding could occur if the short (13 aa) N terminus remained partially shielded beneath the base of the ribosome (see Figures 5H and 5I ), if it remained associated with one or more ER proteins, i.e., TRAM ( Figure 1F ), or if N terminus inversion were slightly delayed relative to C terminus translocation. When fluorescence quenching results are evaluated in the context of photocrosslinking data ( Figures 1C-1E ), they indicate that TM1 inversion is initiated as the nascent chain increases from 98 to 110 aa and is associated with a major transition of TM1 within the proteinaceous environment of the RTC.
Nascent Chain Accumulates within the RTC Prior to TM1 Inversion
To better evaluate nascent chain accessibility, we examined the ability of engineered cysteine residues to undergo covalent modification by an aqueous, membrane-impermeant polyethylene glycol-maleimide derivative, PEG-Mal 5000 ( Figure S3 and Lu and Deutsch, 2005) . In free RNCs, pegylation of Cys44 (L44C) increased and then plateaued as the nascent chain was extended from 71 to 77 aa, indicating that the SH group exits the ribosome as the polypeptide tether from the PTC is extended from 27 to 33 residues in length ( Figures 4A and 4C ). After membrane targeting, however, Cys44 was completely shielded from PEG-Mal, but became accessible upon SDS denaturation (Figures 4B and 4C) . Microsome permeabilization with digitonin and to a lesser extent melittin, also resulted in Cys44 pegylation, but only at nascent chain lengths >110 aa ( Figure 4D ). Thus, these latter agents do not disrupt ribosome binding but allow PEG-Mal to access residues that have entered the ER lumen. In contrast, Figure S2 ). K sv was determined before and after microsome permeabilization with melittin. Results show mean (n R 3 ± SEM).
TX-100 exposed TM1 C-terminal residues to PEG-Mal even at chain lengths of 77-98 aa, indicating that the ribosome-translocon junction is sensitive to certain nonionic detergents ( Figure 4F ). Additional C-terminal residues, Cys34, Cys49, and Cys65, were also shielded from cytosolic and lumenal PEG-Mal in both intact and digitonin-solubilized RTCs at chain lengths %111 aa ( Figures  4E and 5B-5E), whereas the N-terminal residue Cys9 was inaccessible in intact microsomes but pegylated after digitonin permeabilization ( Figure 4G and Figure S4 ). These results confirm that N-terminal residues are exposed to the ER lumen upon membrane targeting and that ribosome binding protects a substantial region of the elongating polypeptide from the cytosol as it accumulates within the RTC prior to TM1 inversion.
Role of the Ribosome Junction in SA Inversion
To determine whether the ribosome plays a direct role in SA inversion, we first tested whether residues that were shielded by the intact RTC but not yet translocated into the ER lumen, might become exposed to cytosol if the ribosome junction were perturbed by addition of 0.5 M NaCl ( Figure 5A ). Prior to salt treatment, low levels of pegylation were observed for Cys residues both within and C-terminal to TM1 (residue 34 and residues 44, 49, and 65, respectively, Figures 5B-5E). Following NaCl addition, no detectable increase in pegylation occurred for residue 34, indicating that the hydrophobic core of TM1 resides in a salt-insensitive environment. However, all three C-terminal residues were pegylated in the presence of NaCl with consistent bimodal peaks at truncations 98 and 111. Ribosome binding therefore establishes electrostatic interactions that shield the nascent chain from cytosol prior to TM inversion. As the nascent chain was extended to 133 aa, salt no longer affected pegylation, satisfying the prediction that high ionic strength should not increase accessibility of cysteine residues after they have translocated into the ER lumen. Unexpectedly, pegylation was partially reduced by salt at truncation 103, the same stage of synthesis at which TM1 photocrosslinking to Sec61a abruptly decreased ( Figures 1C and 1D ). In addition, when microsomes were preincubated in 0.5 M NaCl and resuspended in low-salt buffer, pegylation was reduced to control levels, whereas addition of NaCl to repelleted microsomes increased pegylation irrespective of prior salt treatment (Figures 5F and 5G). Thus, nascent chain shielding by the ribosome translocon junction is reversible, occurs spontaneously, and does not require salt-dissociable factors. We also noted that the increase in cytosolic exposure of Cys44 at truncation 110 in the presence of high salt contrasts with the increase in lumenal I À quenching of L44NBD-Lys following melittin permeabilization. At this chain length, TM1 C-terminal residues can therefore be accessed from either the ER lumen or the cytosol depending upon whether the ribosome-translocon junction remains intact. This suggested that junctional interactions might prevent inappropriate access of the nascent chain to the cytosol, possibly by preventing backsliding during the critical transition of TM1 from a type I to a type II topology. To test this hypothesis, microsomes were digested with RNase to remove ribosomes from arrested RTCs ( Figure S5A ). Figure S4 ). Graphs show mean (n = 3 ± SEM). truncations (R133 aa) resulted in a stable type II topology with Cys9 becoming progressively accessible to cytosolic PEG-Mal ( Figures 5H and 5I ) and Cys49 accessible to lumenal Peg-Mal ( Figure S5C ). These results verify that TM1 inversion involves reciprocal movement of N-and C-terminal flanking residues and indicate that type II topology requires the ribosome to be present at the stage of synthesis when TM inversion is initiated.
PEG-MAL
Topological Inversion Involves Dynamic Protein Interactions at the Ribosome-Translocon Junction
To determine whether protein components contribute to nascent chain shielding, we tested whether the ribosome translocon junction was susceptible to protease digestion. Consistent with previous studies (Jungnickel and Rapoport, 1995; Matlack and Walter, 1995) , short nascent chains were protected from proteinase K (PK) by the RTC ( Figure 6A, lanes 1-8) . However, as (F) RTCs containing L44C (truncated at residue 98 or 110 aa) were incubated with (lanes 3 and 4) or without (lanes 1 and 2) 0.5 M NaCl and pegylated directly (lanes 1-4) or repelleted and pegylated in the presence (lanes 7 and 10) and absence (lanes 6 and 9) of 0.5 M NaCl. the length of polypeptide tether from TM to the PTC increased (truncations 98, 103, 110), PK generated peptidyl-tRNA fragments with increased mobility ( Figure 6A, lanes 9-14) . Labeling nascent chains with a single [ 14 C]Lys residue further demonstrated that PK cleavage occurred between residues 44 and 65, a region of polypeptide that is cytosolically inaccessible in intact RTCs when probed by both quenching and pegylation ( Figure 6B ). These results indicate that polypeptide sequestered in the RTC can become exposed when protein components responsible for shielding are digested. As expected, nascent chains re-acquired partial protease protection at truncations 125 and 133 in intact but not solubilized microsomes. Thus, even though the nascent chain is longer, the effective tether length to the PTC becomes too short to allow PK access beneath the ribosome after translocation of C-terminal residues through the translocon pore ( Figure 6A, lanes 15-20) .
Nascent chains 77 aa in length also remained PK protected following addition of 0.5 M NaCl, whereas truncation 93 became cytosolically accessible ( Figure 6C ). Thus, the peptide tether is marginally long enough for PK to access the nascent chain at this latter stage but only if the ribosome junction is also perturbed by high salt. Paradoxically, NaCl had the opposite effect at truncation 103, converting the junction to a more protease resistant state. This behavior parallels the decrease in pegylation observed at the same chain length ( Figures 4F and 5B-5E ) and indicates that the junction transiently becomes less susceptible to perturbation at this stage of synthesis. As expected, salt had no effect on protease protected nascent chains that achieved a type II topology (truncation 133), although some chains that had not yet fully inverted remained protease accessible. Thus, TM inversion and movement within the translocon coincides with interconversion of the junction between protease-, salt-, and detergent-sensitive and resistant states.
Type I and Type II SAs Diverge at a Late Stage of Topogenesis
Our findings predict that in order to generate different topological outcomes, the events that direct type II and type I SA topology should diverge at some point during synthesis. To determine when this occurs, TM1 was converted to a type I SA by reversing two N-terminal charges (K5D, K14D) and replacing Glu41 with three Arg residues (E41R 3 , Figure 7A ). Type I topology was confirmed by protease protection ($80% of the reporter domain was cytosolic), and N-linked glycosylation (albeit inefficient) of a parallel construct containing an N-linked consensus site (NSS) in a short N-terminal extension ( Figures 7A and 7B and Figure S6B ). Interestingly, glycosylation occurred only in the type I construct and only after the nascent chain reached a length of 135 aa ( Figures S6C and S6D ). This corresponds to the stage of synthesis when TM1 has disengaged from its optimal crosslinking site in Sec61 and N-terminal residues of the type II SA have begun to reorient toward the cytosol. Thus, head-first insertion of the type II SA does not correctly position the consensus site for recognition by OST even though N-terminal residues transiently sample the lumenal environment ( Figure S6) .
Upon membrane targeting, C-terminal residues flanking the type I SA (Cys46, new numbering scheme), like those of the type II SA, became shielded from cytosolic PEG-Mal by a saltsensitive ribosome junction and remained shielded as the nascent chain was extended to at least 112 aa ( Figures 7C and  7D ). For longer truncations (R135 aa), C-terminal residues gradually became cytosolically accessible. This result differs from the type II SA in which C-terminal residues remained shielded from the cytosol, became salt resistant, and were pegylated only after membrane permeabilization. Thus the type I nascent chain emerges from beneath the ribosome at roughly the same stage of synthesis when corresponding residues in the type II SA move into the ER lumen. Consistent with this, the RTC protected short nascent chains (truncations 73-90) containing a type I SA from protease, whereas intermediate lengths (truncations 95-112) were cleaved by PK ( Figure 7E ). At longer truncations (127 and 135 aa), however, less than 20% of typeI chains reacquired protease protection, compare to nearly 50% of type II chains ( Figure 7E ). Early events of membrane targeting, ribosome binding, and nascent chain shielding are therefore similar for type I and type II SAs. However, their respective mechanisms of topogenesis diverge at a relatively late stage when C-terminal flanking residues are either committed for ER translocation or allowed access to the cytosolic compartment.
DISCUSSION
This study provides new insight into membrane protein biogenesis by characterizing the detailed mechanism of type II SA insertion and orientation within the mammalian RTC. When taken together, site-specific photocrosslinking, fluorescence collisional quenching, cysteine accessibility, and protease digestion of programmed integration intermediates provide a remarkably consistent view of the coordinated changes that control nascent chain environment within the RTC, orientation of the SA with respect to the ER membrane, and accessibility of flanking residues to cytosol and ER lumen. Several key findings can be drawn from the present study. First, SA topogenesis involves at least four mechanistically distinct steps that are tightly coupled to incremental changes in nascent chain length. These include (1) ER targeting and head-first insertion into the translocon, (2) accumulation of elongating the nascent chain in a protected proteinaceous environment within the RTC, (3) topological inversion from a type I to a type II topology, and (4) stable translocation of C-terminal flanking residues into the ER lumen. Second, each stage of topogenesis involves discrete, stepwise molecular rearrangements of the SA within the RTC. Third, stable topology is established via a novel intermediate in which nascent chain accessibility is dependent upon reversible and dynamic conformational changes at the ribosome translocon junction.
The first stage of topogenesis occurs as the SA emerges from the ribosome, targets the RNC to the ER membrane, and inserts into Sec61a with its N-terminal residues exposed to the ER lumen. Thus, initial insertion occurs in a head-first (type I) topology as proposed by the Spiess group (Goder and Spiess, 2003) , rather than in the widely depicted hairpin model (Rapoport, 2007; Shaw et al., 1988) . Coincident with these events, protein interactions between the ribosome and translocon shield C-terminal flanking residues from both lumenal and cytosolic compartments. Type II SAs, like N-terminal signal sequences (Crowley et al., 1994) , therefore establish a ''tight'' ribosome-translocon junction that prevents the nascent chain from prematurely accessing the cytosol.
During the second stage of topogenesis, the SA remains in a type I topology but moves into a different molecular environment as evidenced by a 10-fold increase in TM1-Sec61a (B) PK protection of (membrane targeted) type I and type II AQP4-TM1.P ± N-glc. Asterisk indicates full-length protein (see also Figure S6 ). Double asterisk shows a minor population cleaved at a cryptic signal peptidase site (described previously [Foster et al., 2000] ). Cleavage is observed only for truncations >133 aa (not shown). Downward arrow indicates glycosylated band (see also Figure S6 ). Graph shows percent of chains with translocated C terminus (type II topology, mean of two experiments).
(C and D) Mean pegylation efficiency of Cys46 for type I construct (n = 3, ± SEM). Truncations are at same sites as type II constructs, but numbering reflects addition of Arg residues (E41R 3 ). photocrosslinking. C-terminal flanking residues also crosslink Sec61a but remain inaccessible to both the cytosol and ER lumen. Thus a substantial region of polypeptide ($30 aa) accumulates near the ribosome exit tunnel and cytosolic vestibule of Sec61. At this stage of synthesis, perturbation of ribosome binding with high salt and/or PK exposes sequestered polypeptide to cytosolic agents. This could occur by disrupting electrostatic interactions between Sec61a (e.g., L6, L8, and C terminus) and ribosomal RNA (H50, H53, H24) and/or ribosomal proteins (rpl17, rpL25, rpl26) (Becker et al., 2009; Cheng et al., 2005; Pool, 2009) . Alternatively, because the ribosome protects Sec61 from proteolytic attack (Kalies et al., 1994) , salt and protease effects could be mediated by interactions with additional translocon-associated proteins such as oligosaccharyltransferase, TRAP, TRAM, or others (Hegde and Lingappa, 1996; Pool, 2009; Shibatani et al., 2005) . The third stage of topogenesis involves a metastable intermediate that heralds the onset of TM1 inversion. At a nascent chain length of 98 aa, TM1 is in a type I topology and tethered to the PTC by a span of 62 residues, a length nominally sufficient to traverse the ribosome exit tunnel and translocon (Mingarro et al., 2000) . Synthesis of only 5 additional residues (truncation 103) displaces the SA from its site adjacent to Sec61a and transiently converts the ribosome translocon junction to a salt-and TX-100-resistant state. This is followed, at truncation 110, by an abrupt increase in the lumenal accessibility of C-terminal residues, reflecting either initial SA inversion or a structural change in the translocon that allows I À to access the nascent chain from the ER lumen (Crowley et al., 1993 (Crowley et al., , 1994 . Remarkably, these C-terminal flanking residues become cytosolically accessible when ribosome binding is perturbed by either high salt or proteolytic digestion. The abrupt transition in lumenal accessibility is therefore coupled to physical displacement of the SA within the RTC and simultaneous alteration of junctional interactions that prevent premature access to the cytosol. The final stage of topogenesis is characterized by TM1 inversion and acquisition of a stable type II topology. At chain lengths of 125-133 aa, fluorescence quenching, pegylation and protease protection invariably support the translocation of TM1 C-terminal residues into the ER lumen. The short N terminus, which remains shielded by the ribosome, also becomes cytosolically accessible upon ribosome removal, although full exposure may be somewhat delayed. As the tether length between TM1 and the PTC is increased, nascent chain topology becomes independent of ribosome binding and is likely stabilized by other interactions with Sec61, TRAM, lipids, and/or possibly lumenal components. Notably, the type II SA diverges from the type I SA at this stage of synthesis, when C-terminal flanking residues are either committed to translocate into the ER lumen or move into the cytosol.
One question arising from these findings is how the translocon mediates this remarkable sequence of events. Crystal structures of SecY together with crosslinking studies have suggested that signal sequences insert into a lateral cleft between TM 2b and TM7 of Sec61 (Plath et al., 2004; van den Berg et al., 2004) , thereby opening the translocon pore and initiating translocation (Cannon et al., 2005) . In contrast to the hairpin-loop model where C-terminal residues enter the pore coincident with SA insertion (Rapoport, 2007; Shaw et al., 1988) , the present study implicates a mechanism in which N-terminal flanking residues are initially translocated into the ER, and opening of the lumenal pore and C terminus translocation occur at a later stage of translation. Systematic changes in Sec61a photocrosslinking therefore indicate that the proteinaceous interior of the translocon either contains multiple sites that can accommodate the SA or a highly dynamic site whose character changes significantly during the inversion process. This concept is supported by the ability of OST to modify lumenal N-linked glycosylation consensus sites only during the last stage of topogenesis. One possibility is that the increase in early Sec61a crosslinking (truncations 71-98) coincides with SA movement into the lateral gate, whereas the subsequent decrease (truncations 98-104) reflects partial release from this site as inversion is initiated.
An intriguing and still enigmatic issue is how N-terminal residues return to the cytosol as C terminus translocation is initiated. While multiple peptide strands might be accommodated within alternate translocation pathways (Kida et al., 2007) , recent studies have implicated a monomeric protein conducting channel as the functional unit (Becker et al., 2009) . A single Sec61abg heterotrimer, however, is clearly too small to accommodate rotation of a rigid helix. Therefore, either Sec61 together with its accessory proteins must provide sufficient space for helix inversion and transport of N-and C-terminal residues, TM1 must exhibit a significant degree of flexibility/unfolding, or inversion must take place at least partially outside but adjacent to Sec61a (Brambillasca et al., 2006; Kida et al., 2010) . Structural studies of fully assembled translocons containing RNCs at different stages of topogenesis will likely be needed to resolve these scenarios.
What then provides the driving force for SA inversion? The final orientation of an SA is determined in part by the balance between hydrophobic and electrostatic interactions with Sec61a (Higy et al., 2004) , TRAM (Mothes et al., 1994) , and/or membrane lipids (Dowhan and Bogdanov, 2009; Hessa et al., 2007) . TM1 N and C termini contain a net charge of +3 and À1, respectively, thereby favoring a type II topology according to the ''positive inside rule '' (von Heijne, 2006) . To explain our findings, we propose a simple model in which the translocon mediates SA topogenesis by catalyzing two sequential energetic transitions: (1) insertion, which is driven primarily by the hydrophobic effect and (2) inversion, which is driven by electrostatic interactions. Because TM1 is highly hydrophobic, initial insertion into the translocon is likely stabilized by decreased exposure to aqueous solvent (Hessa et al., 2007; Junne et al., 2010) . At the same time, insertion may induce an electrostatic strain from the oriented dipole moment in ribosome-bound Sec61 (Higy et al., 2004) . Such a model would predict the existence of transient intermediates at early stages of synthesis where topology is dependent on the net outcome of these forces. Indeed, reversing the net flanking charge (N, À1; C, +3) converted TM1 to a type I SA but had no detectable effect on ribosome shielding at short nascent chain lengths. Thus, initial targeting and insertion events are similar irrespective of the final topological outcome. As the nascent chain reaches a critical length (127-133 in this construct), ribosome binding is required for inversion of the type II SA, whereas shielding becomes diminished for the type I SA and C-terminal residues are directed into the cytosol. Importantly, head-first insertion is not necessarily a prerequisite step for all SAs. Hairpin insertion could result if the energetic cost of maintaining the SA (or signal sequence) in the aqueous space beneath the ribosome were less than the electrostatic strain (Shaw et al., 1988; von Heijne, 2006) or if the SA were preceded by a large globular domain which could slow or block insertion kinetics. The mode of insertion would also be dependent on additional parameters including the rate of translation, kinetics of SRP release after membrane targeting, and the rate of RNC transfer to Sec61 (Song et al., 2000) . If, for example, translation (after SRP release of the SA) proceeded faster than insertion, then sufficient nascent chain could potentially accumulate beneath the ribosome to allow for hairpin insertion.
Our model also predicts that for inversion to take place, TM1 should disengage from its initial (hydrophobic) binding site in Sec61. The resulting increase in rotational freedom could then be coupled either directly or indirectly through conformational changes at the ribosome junction that ensure C terminus translocation, and thereby relieve electrostatic strain as the tether is lengthened. Both of these requirements, TM1 displacement and altered junctional interactions, were observed at truncation 103. While the events that trigger these conformational changes remain uncertain, they are likely mediated by the location, orientation, and physical properties of the SA as has been proposed for N-terminal signal sequences (Rutkowski et al., 2001) . It is tempting to speculate that dynamic communication between the ribosome and translocon identified here contribute to the transient cytosolic exposure of secretory proteins induced by pause transfer sequences (Hegde and Lingappa, 1996) , inefficient translocation observed for a subset of N-terminal signal sequences (Kim et al., 2002) , and possibly selective effects of certain translocation inhibitors (Garrison et al., 2005) . The observation that topological transitions are tightly coupled to nascent chain length is also significant for polytopic membrane proteins where multiple translocation events are required to deliver peptide loops into the ER lumen (Sadlish et al., 2005) . A future challenge, therefore, is to determine how the translocon accommodates the diverse repertoire of natural SAs and whether yet additional mechanisms of translocation initiation and reinitiation are possible.
EXPERIMENTAL PROCEDURES
Plasmid Construction AQP4 TM1 fusion protein (AQP4-TM1.P) contains AQP4 residues Met1 to Val46, a Thr-Val linker, and the C-terminal 142 residues from bovine prolactin in a pSP64 (Promega) vector described elsewhere (Foster et al., 2000) . Indicated mutations were incorporated into the coding sequence using PCR overlap extension. A glycosylation site was inserted N-terminal to TM1 by replacing Met1 with cDNA encoding MGNSS.
In Vitro Transcription/Translation AQP4-TM1.P cDNA was amplified by PCR, transcribed in vitro using SP6 RNA polymerase, and translated in rabbit reticulocyte lysate (RRL) in the presence or absence of canine pancreatic microsomes. Where indicated [ ) was added to final concentration of 0.8-1.0 mM. tRNAs were synthesized, modified, and purified as described previously (Sadlish et al., 2005) . For biochemical studies, RNCs and microsomes were isolated by pelleting and resuspended in 50 mM HEPES-KOH (pH 7.5), 100 mM KCl, 5 mM MgCl 2 , and 1 mM DTT with (microsomes) or without (RNCs) 0.1 M sucrose.
Photocrosslinking Nascent chains containing 3ANB-Lys-tRNA amb were exposed to UV irradiation on ice for 10 min and were either analyzed directly by SDS-PAGE ( Figure S1 ) or immunoprecipitated following SDS denaturation. Radiolabeled bands were quantified by phosphorimaging as described previously (Sadlish et al., 2005) .
Fluorescence Quenching
Parallel translation reactions containing 3NBD-[ 14 C]Lys-tRNA amb or [ 14 C]LystRNA amb (spectral control) were performed and subjected to gel filtration with Sephadex CL-6B or CL-2B to isolate free and membrane-bound RNCs, respectively. Baseline steady-state NBD emission intensity was measured using a Fluorolog 3-2-2 fluorimeter (Horiba Scientific) prior to and following addition of KI solution and melittin (for membrane bound RNCs) essentially as described previously (Crowley et al., 1994) . Quenching constants were determined using the Stern-Volmer equation:
where F 0 is the net initial emission intensity and F is the emission intensity after addition of [I À ]. K sv = k q t where k q is the bimolecular quenching constant and t is the fluorescence lifetime. Because t, and hence the emission intensity, is environmentally sensitive, the emission intensity per nM concentration of 3NBD-[ 14 C]Lys incorporated (i.e., photons/sec/nM) was determined at the end of each experiment for each sample using the photon counting and Mass Tagging with PEG-MAL Pelleted microsomes and RNCs were incubated on ice with 2 mM PEG-Mal 5000 (Biochimika) and 50 mM DTT. Where indicated, 0.2% (w/v) SDS, 1% (v/v) Triton X-100, 2% (w/v) digitonin, and 1.6 mM melittin or 0.5 M NaCl were added prior to PEG-Mal. Where indicated, samples were incubated with (10 mg/ml) RNase or 1 mM puromycin prior to addition of PEG-Mal. The reaction was quenched by addition of equal volume of 400 mM DTT and added directly to SDS-loading buffer. Pegylation efficiency was calculated from the band intensities of pegylated (P) and unpegylated (UP) peptidyl-tRNA bands using the formula: Fraction Pegylated = P/(UP+P).
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